Previous Close | 1.1800 |
Open | 0.3600 |
Bid | 0.0000 |
Ask | 0.5000 |
Strike | 22.50 |
Expire Date | 2024-06-21 |
Day's Range | 0.3600 - 0.3600 |
Contract Range | N/A |
Volume | |
Open Interest | 99 |
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
CAMBRIDGE, England & BOSTON, June 03, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in June:
Bicycle Therapeutics (BCYC) gains 10% upon entering a PIPE financing agreement with multiple institutional investors, which is expected to generate gross proceeds of $555 million.